BioNTech SE (BNTX) Intangibles (2018 - 2025)
BioNTech SE's (BNTX) quarterly Intangibles came in at $1.9 billion in Q4 2025, up 121.34% year-on-year from $844.6 million in Q4 2024, and up 15.06% quarter-over-quarter from $1.6 billion in Q3 2025.
BioNTech SE (BNTX) Intangibles (2018 - 2025) Analysis & Trends
BioNTech SE has disclosed Intangibles across 8 years of filings, most recently posting $1.9 billion for Q4 2025.
- Intangibles for Q4 2025 came in at $1.9 billion, up 121.34% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.9 billion (up 121.34% YoY), and the FY2025 annual result was $1.8 billion, up 114.83% from the prior year.
- Intangibles came in at $1.9 billion for Q4 2025 at BioNTech SE, up from $1.6 billion in the prior quarter.
- In the past five years, Intangibles ranged from a high of $1.9 billion in Q4 2025 to a low of -$78.5 million in Q4 2022.
- The 5-year median for Intangibles is $635.2 million (2023), against an average of $710.9 million.
- Across the five-year window, Intangibles slumped 218.66% in 2022 and surged 1202.72% in 2023, its largest moves.
- BioNTech SE's Intangibles stood at $66.1 million in 2021, then plunged by 218.66% to -$78.5 million in 2022, then soared by 1202.72% to $865.2 million in 2023, then declined by 2.37% to $844.6 million in 2024, then jumped by 121.34% to $1.9 billion in 2025.
- The last three Intangibles figures came in at $1.9 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.7 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn | 1.87 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.87 Bn |
| Sep 30, 2025 | 1.62 Bn |
| Jun 30, 2025 | 1.68 Bn |
| Mar 31, 2025 | 1.59 Bn |
| Dec 31, 2024 | 844.62 Mn |
| Sep 30, 2024 | 959.73 Mn |
| Jun 30, 2024 | 928.60 Mn |
| Mar 31, 2024 | 892.66 Mn |
| Dec 31, 2023 | 865.16 Mn |
| Sep 30, 2023 | 724.46 Mn |
| Jun 30, 2023 | 545.99 Mn |
| Mar 31, 2023 | 406.37 Mn |
| Dec 31, 2022 | -78.46 Mn |
| Sep 30, 2022 | 228.07 Mn |
| Jun 30, 2022 | 236.25 Mn |
| Mar 31, 2022 | 242.42 Mn |
| Dec 31, 2021 | 66.12 Mn |
| Sep 30, 2021 | 192.11 Mn |
| Jun 30, 2021 | 197.62 Mn |
| Mar 31, 2021 | 199.27 Mn |